台股 » 旭富 » 個股財報 » 營收成長率(年增率)
- 股價
89.8
- 漲跌
▲0.3
- 漲幅
+0.34%
- 成交量
52張
- 產業
上市 生技醫療類股
▲0.86%
-
本地時間:13:30
旭富 (4119) 財務報表－營收成長率(年增率)
營收成長率
營收季增率 = (單季營收÷上季營收)-1。
營收年增率 = (單季營收÷去年同季營收)-1。
旭富 (4119) 歷年營收年增率
| 年度/季別 | 營收年增率 | 近4季營收年增率 | 年度/季別 | 營收年增率 | 近4季營收年增率 |
|---|
| 2024Q2 | 25.42% | 5.62% | 2021Q3 | -66.38% | -54.76% |
| 2024Q1 | -9.33% | 11.27% | 2021Q2 | -75.74% | -36.95% |
| 2023Q4 | 29.08% | 33.83% | 2021Q1 | -58.74% | -12.14% |
| 2023Q3 | -15.35% | 40.60% | 2020Q4 | -4.20% | 14.16% |
| 2023Q2 | 72.65% | 61.61% | 2020Q3 | 8.13% | 17.86% |
| 2023Q1 | 81.78% | 44.59% | 2020Q2 | 20.46% | 21.36% |
| 2022Q4 | 66.29% | 4.11% | 2020Q1 | 29.92% | 19.76% |
| 2022Q3 | 33.44% | -33.98% | 2019Q4 | 11.96% | 21.44% |
| 2022Q2 | 2.71% | -56.27% | 2019Q3 | 20.87% | 27.18% |
| 2022Q1 | -41.90% | -67.30% | 2019Q2 | 13.92% | 33.30% |
| 2021Q4 | -72.75% | -67.86% | 2019Q1 | 41.83% | 51.48% |
水星生醫*攜手旭富製藥 簽訂MTA開發抗癲癇藥物Anue鉅亨－2024/04/15
旭富新產能到位本季營運看增 觀音新廠產能再增5成Anue鉅亨－2023/10/03
星國阿茲海默三期順利解盲 旭富獨供原料藥營運吞補丸Anue鉅亨－2022/11/23